ArticleGastroenterology research2026

Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Jonathan Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.